Authors: Carrieri, MP Vlahov, D Dellamonica, P Gallais, H Lepeu, G Spire, B Obadia, Y

Citation: Mp. Carrieri et al., Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART, DRUG AL DEP, 60(1), 2000, pp. 51-54

Authors: Tamalet, C Pasquier, C Yahi, N Colson, P Poizot-Martin, I Lepeu, G Gallais, H Massip, P Puel, J Izopet, J

Citation: C. Tamalet et al., Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection, J MED VIROL, 61(2), 2000, pp. 181-186

Authors: Bouabdallah, R Stoppa, AM Rossi, JF Lepeu, G Coso, D Xerri, L Ladaique, P Chabannon, C Blaise, D Bardou, VJ Alzieu, C Gastaut, JA Maraninchi, D

Citation: R. Bouabdallah et al., Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patients, LEUKEMIA, 13(6), 1999, pp. 950-956

Authors: Zou, WP Foussat, A Houhou, S Durand-Gasselin, I Dulioust, A Bouchet, L Galanaud, P Levy, Y Emilie, D Aboulker, JP Capitant, C Boue, F Bouvet, E Karmochkinc, M Kazatchkine, M Oksenhendler, E Viard, JP Weiss, L Yeni, P Delfraissy, JF Goujard, C Jarrousse, B Lepeu, G Cartier, F Bazin, C Six, M Gastaut, JA Seligmann, M Herrerra, A Maral, J

Citation: Wp. Zou et al., Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2, AIDS, 13(4), 1999, pp. 455-463